Health Products
The Curriculum in Health Products will focus on acquiring highly diverse skills, ranging from design to synthesis and pharmaceutical analysis, offering a comprehensive and multidisciplinary approach to the field. Particular emphasis will be placed on drug delivery, both synthetic and biotechnological, with the aim of understanding and optimizing delivery processes to ensure the effectiveness and safety of treatments. Additionally, the curriculum will delve into preclinical application aspects, including in silico simulations, in vitro tests, and in vivo experiments, to evaluate the efficacy and toxicity of drugs before their clinical application.
Another key element of the curriculum will be the analysis of the industrial transfer of results obtained in academia, aiming to foster collaboration between the research and industrial sectors to maximize the impact of results on public health. This includes the study of regulatory aspects related to the pharmaceutical industry, to ensure that the developed drugs meet the safety and quality standards required by regulatory authorities.
Through an interdisciplinary and integrated approach, the Curriculum in Health Products aims to train highly qualified professionals prepared to face the challenges of the modern pharmaceutical sector. Participants will have the opportunity to acquire practical and theoretical skills through courses, seminars, and research projects guided by industry experts.
Coordinator Prof. Giulio Rastelli – FACULTY MEMBERS
Health Technologies
The Curriculum in Health Technologies will focus on acquiring specific skills in clinical transfer and the preclinical phase, with particular attention to diseases of significant impact and health interest. These include chronic diseases characterized by inflammation, altered immune response, degeneration, or oncogenesis, as well as infectious and rare genetic diseases. Additionally, the curriculum will delve into innovative diagnostic and therapeutic techniques, ranging from the experimentation of non-invasive methods, cellular engineering, and gene therapy to robotic surgery, aiming to provide advanced and personalized solutions for patient care.
A key objective of the curriculum will be the application of artificial intelligence in the fields of pharmaceuticals and health to provide comprehensive training on the use of AI and machine learning technologies in the medical-pharmaceutical sector. This objective, building on previous experiences in anesthesiology in cardiac surgery, aims to create a broader network of interactions that also involves the pharmaceutical and biotechnological sectors, thus contributing to the internationalization of the doctoral program. Regarding the application of artificial intelligence, the primary goal will be to provide knowledge on the use of AI technologies in the fields of pharmaceuticals and health.
Coordinator Prof. Giuseppe Biagini – FACULTY MEMBERS